Greg brought 30 years of experience in the pharmaceutical, biotechnology and packaged-goods industries when he joined Organigram in 2017. His focus with the company – one of Canada’s leading licensed producers of medical cannabis – is on product quality and safety as well as production efficiencies. Greg also is overseeing the expansion of Organigram’s production facility in Moncton that will help ease the publicly traded firm’s move into Canada’s impending recreational market.
Greg Engel
